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Abstract
Sepsis-induced immune reactions are reduced in TNF receptor 2 (TNFR2)-deficient mice as previously shown. In order
to elucidate the underlying mechanisms, the functional integrity of myeloid cells of TNFR2-deficient mice was analyzed
and compared to wild type (WT) mice. The capacity of dendritic cells to produce IL-12 was strongly impaired in TNF-
deficient mice, mirroring impaired production of IL-12 by WT dendritic cells in sepsis or after LPS or TNF pre-treatment.
In addition, TNFR2-deficient mice were refractory to LPS pre-treatment and also to hyper-sensitization by inactivated
Propionibacterium acnes, indicating habituation to inflammatory stimuli by the immune response when TNFR2 is lacking.
Constitutive expression of TNF mRNA in kidney, liver, spleen, colon and lung tissue, and the presence of soluble TNFR2
in urine of healthy WT mice supported the conclusion that TNF is continuously present in naı¨ve mice and controlled by
soluble TNFR2. In TNFR2-deficient mice endogenous TNF levels cannot be balanced and the continuous exposure to
enhanced TNF levels impairs dendritic cell function. In conclusion, TNF pre-exposure suppresses secondary inflamma-
tory reactions of myeloid cells; therefore, continuous control of endogenous TNF by soluble TNFR2 seems to be
essential for the maintenance of adequate sensitivity to inflammatory stimuli.
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Introduction
TNF, a key cytokine induced by inﬂammatory stimuli,
has a wide range of biological functions. This is prob-
ably owing to the fact that it exists in two biologically
active forms, as a soluble and as a trans-membrane
molecule. In addition, the two forms interact diﬀeren-
tially with two types of receptors, TNF receptor type 1
(TNFR1) and TNF receptor type 2 (TNFR2), which
activate diﬀerent signaling pathways.1 Both receptors
can be detected on the surface of a number of diﬀerent
cell types, with TNFR1 being constitutively expressed
on many cell types, while the expression of TNFR2 is
highly regulated and mainly restricted to immune
cells.2 In addition, the two TNFRs can be cleaved oﬀ
membranes and act as soluble TNF scavengers.
TNFR2, in particular, is released in large quantities
during inﬂammation and acts as functional inhibitor
of TNF.
TNFR1 is the principal receptor on most cell types,
triggering inﬂammatory signals classically attributed to
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TNF, such as triggering cytotoxic and inﬂammatory
processes.3,4 Important TNFR1-dependent signaling
pathways include pathways that result in activation of
NF-kB, Jun N-terminal kinase, MAPK and others.
Consequently, TNFR1-deﬁcient mice are resistant to
endotoxic shock and demonstrate an impaired defense
to bacterial pathogens.5,6
Soluble TNFR2 is generally considered to attenuate
TNF responses by scavenging TNF.4 The physiological
role of signal transmission through TNFR2, however,
is not entirely clear and genetic ablation of the gene for
TNFR2 did not result in a mouse line with a strong
phenotype. Membrane TNFR2 was found to enhance
TNFR1-induced apoptosis, ﬁrst believed to be due to a
phenomenon called ‘ligand passing’7 and, later, to
intracellular signaling.8,9 With respect to inﬂammatory
pathways, both synergistic and antagonizing activities
of TNFR1 and TNFR2 have been described. The
diﬀerential interaction of membrane-bound versus
soluble TNF with TNFR1 and/or TNFR2, respect-
ively, led to the conclusion that both TNF receptors
might cooperate in TNF-induced inﬂammatory
responses.10,11 However, the precise role of TNFR2
in sepsis, where TNFR1 deﬁnitely is responsible for
the inﬂammatory reaction as outlined above, has not
been clariﬁed. Interestingly, TNFR2-deﬁcient mice
were resistant to changes of the immune status induced
by sepsis, such as increased susceptibility to subsequent
infections12 and increased numbers of regulatory
T cells.13
We used TNFR2-deﬁcient mice to investigate
whether TNFR2 might play a decisive role modulating
immune responses after cecal ligation and puncture
(CLP), a mouse model for induction of poly-microbial
peritonitis. Assuming that dendritic cells (DC), which
play a central role in linking innate with adaptive
immune responses, provide a clue for the function of
TNFR2, we compared primary DC from TNFR2-
deﬁcient and wild type (WT) mice and detected
impaired Ag presenting capacity of TNFR2-deﬁcient
DC after CLP. This phenotypic characterization of
DC should help to mechanistically understand and
interpret previous observations made in experimental
mouse models using TNFR2-deﬁcient mice.
Material and methods
Animals
C57BL/6 mice were purchased from Janvier (Le
Genest, France). TNFR2-deﬁcient mice (C57BL/6-
Tnfrsf1btm1Mwm)14 were purchased from The Jackson
Laboratory (Bar Harbour, ME, USA), and deﬁciency
of TNFR2 expression was veriﬁed by PCR. Mice were
housed in the animal facility of the University of
Regensburg and handled in accordance with institu-
tional guidelines.
Cells
Peripheral mononuclear cells were isolated from blood
by density gradient separation. Blood containing EDTA
was placed onto Pancoll (PAN-Biotech, Aidenbach,
Germany) and interphase was harvested after centrifu-
gation. Following washing, cells were placed in culture.
CD11c-positive cells were isolated by magnetic-
activated cell sorting (MACS) from splenic single cell
suspensions following the manufacturer’s protocol
(Miltenyi Biotec, Bergisch Gladbach, Germany). For
generation of bone marrow-derived DC (BMDC),
mice were killed and femura and tibiae dissected,
quickly placed in 70% aqueous ethanol, both ends cut
and bone marrow ﬂushed out with PBS. Cells were
washed once with medium and re-suspended in RPMI
medium containing granulocyte–macrophage colony-
stimulating factor (GM-CSF) for generation of
BMDC as described previously.15
CLP
Mice were anesthetized (75mg/kg Ketanest; Parke,
Davis & Company, Munich, Germany) and 16mg/kg
Rompun (Bayer AG, Leverkusen, Germany) i.p. The
cecum was exteriorized and 30% of the distal end was
ligated and punctured once with a 27-G needle to
achieve a sublethal CLP.16
Flow cytometry
Following lysis of red blood cells (RBC) in blood and
splenic single cell suspensions, cells were incubated with
Abs against CD16/32 to block non-speciﬁc Ab binding
and stained with ﬂuorochrome-labeled Abs.
Intracellular cytokines were detected using the
Cytoﬁx/Cytoperm kit (BD Biosciences, Heidelberg,
Germany). Fluorochrome- or biotin-labeled Abs
detecting mouse CD11c, CD11b, CD4, CD8a, B220,
Ly6C, Ly6G, CD86, CD80, IL-12p40, IFN-g and
MHC-II, as well as ﬂuorochrome-labeled streptavidin,
were purchased from BD Biosciences, eBioscience
(Frankfurt, Germany), Miltenyi Biotec (Bergisch
Gladbach, Germany) or Invitrogen (Darmstadt,
Germany). Cells were measured on a BD LSR-II or a
BD FACSCalibur ﬂow cytometer, and analyzed using
the FacsDiva or CellQuest softwares (BD Biosciences).
Cytokine production
Splenic single cell suspensions after lysis of RBC or
BMDC were cultured with cell culture medium
(RPMI 1640 with 10% FCS, Pen/Strep, 50 mM 2-ME)
at 37C. For detection of IL-12p40-producing cells,
cells were cultured for 4 h in the presence of
Monensin (GolgiStop; BD Biosciences), usually stimu-
lated with 5 mg/ml cytosin–guanosin oligonucleotid
ODN 1668 (CpG; Metabion, Munich, Germany),
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but without CpG stimulation in the LPS tolerance
experiments. For IL-12 family mRNA detection, cells
were stimulated with CpG for 6 h. ELISA kits were
used for quantiﬁcation of IL-12p70 (Bender
MedSystems, Vienna, Austria) in supernatants of 18-h
cultures with CpG, and for quantiﬁcation of IFN-g
(R&D Systems, Wiesbaden, Germany) in serum.
Ag presentation
CD11c+ cells were isolated from splenocytes by mag-
netic separation with anti-CD11c beads, and CD4+ T
cells were isolated from splenocytes of OT-II mice with
anti-CD4 beads according to the manufacturer’s
instructions (Miltenyi Biotec). OT-II CD4+ T cells
were labeled with 1 mM 5,6-carboxyﬂuorescein succini-
midyl ester (CFSE) and 2 105 cells were incubated
with 4 104 CD11c+ cells and varying concentrations
of ovalbumin (OVA). CFSE dilution was analyzed after
72 h of culture by ﬂow cytometry to quantify
proliferation.
Quantitative real-time PCR
RNA was prepared from samples using the Nucleospin
RNA II kit according to the manufacturer’s instruction
(Macherey-Nagel, Du¨ren, Germany) and cDNA was
generated by transcription with Moloney murine leuke-
mia virus reverse transcriptase (MMLV), (Promega,
Mannheim, Germany). Primers for IL-12p35 mRNA
(forward: TGT CAA TCA CGC TAC CTC CTC;
reverse: TTT TCT CTG GCC GTC TTC AC), IL-
12p40 mRNA (forward: TCA GGG ACA TCA TCA
AAC CA; reverse: CTT TCT GGT TAC ACC CCT
CCT), TNF mRNA (forward: CCC CAA AGG GAT
GAG AAG TT; reverse: CAC TTG GTG GTT TGC
TAC GA), 18S rRNA (forward: GTA ACC CGT
TGA ACC CCA TT; reverse: CCA TCC AAT CGG
TAG TAG CG) and b-actin (forward: TCA CCC ACA
CTGTGCCCATCTACGA; reverse:GGATGCCAC
AGG ATT CCA TAC CCA) were purchased from
Metabion (Martinsried, Germany). Real-time PCR was
performedwith the iQ SYBRGreen SuperMix (BioRad,
Munich, Germany) on an iQ5 iCycler (BioRad) with 40
cycles (20 s at 95C, 30 s at 58C, 30 s at 72C).
Mouse models
LPS tolerance model.17 Mice were challenged 24 h after
pre-treatment with either LPS from Escherichia coli
0127:B8 or human TNF (0.025mg/mouse, i.v.) with
LPS (0.1mg/mouse, i.v.), and spleen was sampled
90min later.
Propionibacterium acnes sensitizing model. Dead Propioni-
bacterium acnes was injected (0.02 g/kg in 0.2ml PBS,
i.v.) and 7 d later mice were challenged with LPS from
Salmonella Abortus Equi (0.01 mg/kg in 0.2ml PBS,
i.v.). Four h after LPS injection serum IFN-g levels
were determined.
Statistics. Unpaired Student’s t-test or two-way
ANOVA with Bonferroni post hoc test were used in
experiments with two or more experimental groups.
P< 0.05 was accepted as signiﬁcantly diﬀerent. All stat-
istics were performed using GraphPad Prism 5.0
(GraphPad Software, La Jolla, CA, USA). All data
shown in ﬁgures are representative of 2–3 experiments
(except for Figure 2a, which was done once).
Results
Sepsis reduces lymphocyte population
in TNFR2-deficient mice
First, we analyzed the impact of TNFR2-deﬁciency
on splenic cell populations in naı¨ve mice and after
CLP (Table 1). In naı¨ve mice, the only diﬀerence
between the two mouse lines consisted of lower num-
bers of splenic CD4+ T cells in TNFR2-deﬁcient mice.
We have previously shown that total cell, B and T cell
numbers in the spleen are reduced 2 d after CLP.18
Here, we detected a similar reduction of total spleno-
cytes and splenic lymphocyte numbers after CLP in
TNFR2-deﬁcient mice. However, CLP hardly aﬀected
the cell numbers of CD11b+ in TNFR2-deﬁcient mice.
CD11b+ cell numbers were signiﬁcantly higher in
septic TNFR2-deﬁcient compared with septic WT
mice. This strong diﬀerence between WT and
TNFR2-deﬁcient mice was induced by CLP in cell
populations identiﬁed as inﬂammatory myeloid cells
or myeloid-derived suppressor cells [MO-MDSC, iden-
tiﬁed as CD11b+ Ly6Chi Ly6G-, and polymorpho-
nuclear (PMN)-MDSC, identiﬁed as CD11b+ Ly6Cint
Ly6G+].19 CLP reduced the number of splenic MO-
MDSC and PMN-MDSC strongly in WT mice, but it
did not change the numbers in TNFR2-deﬁcient mice.
We also compared activation markers on myeloid
CD11b+ and CD11c+ cells in both mouse lines
(Table 2). Two d after sepsis, activation markers on
splenic WT CD11b+ cells had a tendency to be
increased, as we have observed previously.18 This
eﬀect was also seen in TNFR2-deﬁcient mice.
Production of IL-12 of splenic DC from
TNFR2-deficient mice is impaired
Next, we analyzed the impact of CLP and TNFR2 on
DC function by harvesting DC 2 d after CLP and acti-
vating them in vitro. Stimulation of splenic DC with
CpG resulted in lower levels of IL-12p70, as well as
in reduced numbers of IL-12p40-producing DC in
naı¨ve TNFR2-deﬁcient compared with naı¨ve WT mice
(Figure 1a, b). Also, the fraction of IL-12-producing
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DC was found to be similarly reduced in CpG-
stimulated DC from blood of naı¨ve TNFR2-deﬁcient
mice (Figure 1c).
Sepsis lowered the percentage of IL-12p40-positive
splenic DC and signiﬁcantly reduced the production of
IL-12p70 by DC isolated from spleens of WT mice, as
previously described.20,21 Even though TNFR2-
deﬁcient splenic DC started oﬀ at a much lower level
when derived from naı¨ve mice, an additional sepsis-
induced reduction in IL-12p40-positive splenic DC
ratio and IL-12p70 production was seen in DC from
septic TNFR2-deﬁcient mice (Figure 1a, b). This CLP-
induced reduction in IL-12p70 in TNFR2-deﬁcient mice
was still signiﬁcant, while no signiﬁcant reduction was
measured in the percentage of IL-12p40-positive
CD11+ cells. CpG-induced mRNA expression levels
of proteins constituting the IL-12 family (p40, p35,
p19, p28 and Ebi 3) were determined. All tested genes,
and, in particular, genes coding for p40 and p35, were
found to be more strongly expressed in DC from naı¨ve
WT than in naı¨ve TNFR2-deﬁcient mice, supporting the
IL-12 protein data (Figure 1d and data not shown).
As it was previously shown that CLP leads to epi-
genetic changes in DC,21 we wondered if the reduced
IL-12 production by DC from TNFR2-deﬁcient mice is
based on similar alterations. To investigate if precursor
cells of DC in the bone marrow are already destined to
have an IL-12 production deﬁciency owing to (possibly
epigenetic) alterations, BMDC from both mouse lines
were generated by culturing bone marrow cells in the
presence of GM-CSF. The resulting BMDC from the
two mouse lines showed equal IL-12 production after
CpG stimulation (data not shown) and not the reduced
IL-12 production phenotype seen with splenic DC from
TNFR2-deﬁcient mice. The changes in IL-12 produc-
tion could be based on the lack of TNFR2 on the DC
themselves, or on a general change in the microenvir-
onment in TNFR2-deﬁcient mice. In order to clarify
Table 1. Splenic lymphocyte populations in naive and septic WT and TNFR2-deficient mice.
C57BL/6 WT mice (106 cells) TNFR2-deficient mice (106 cells) Significance WT/TNFR2-def.
Untreated CLP S Untreated CLP S Untreated CLP
Total cells 97.4 3.9 57.2 13.3 * 85.6 10.4 50.8 12.7 * NS NS
B cells 48.5 3.0 18.3 7.2 * 43.7 6.7 20.7 7.5 * NS NS
CD4+T cells 19.8 1.4 14.2 3.7 * 13.8 1.3 9.8 1.8 * * *
CD8+ T cells 15.0 1.4 18.5 2.4 * 12.8 1.2 11.7 2.5 NS NS *
CD11b+ cells 3.86 0.79 1.68 0.56 * 4.56 0.87 4.20 0.21 NS NS *
CD11c+ cells 1.85 0.42 0.41 0.09 * 1.91 0.20 0.51 0.08 * NS NS
MO-MDSC 0.67 0.19 0.34 0.13 NS 0.81 0.20 0.89 0.06 NS NS *
PMN-MDSC 0.73 0.14 0.15 0.08 NS 0.98 0.23 1.03 0.79 NS NS *
Splenocytes were analyzed in untreated mice or 2 d after CLP. Data are given as mean SD (n¼ 5–7). The columns labeled ‘S’ give the statistical
significances for untreated versus CLP-treated mice of the respective mouse line; the last column gives the statistical significances between the two
mouse lines within the untreated or the CLP-treated mice. Significance was calculated with Bonferroni post hoc test following a two-way ANOVA. NS:
no significant effect. *P< 0.05.
Table 2. Activation markers of myeloid cells in naı¨ve and septic WT and TNFR2-deficient mice.
C57BL/6 WT mice TNFR2-deficient mice Significance WT/TNFR2-def.
Untreated CLP S Untreated CLP S Untreated CLP
CD11b+
MHC-II+ 28.9 4.3% 30.2 5.3% NS 23.8 3.2% 24.3 5.4% NS NS NS
CD86+ 13.0 2.2% 17.8 4.4% NS 10.6 3.6% 16.8 4.9% * NS NS
CD80+ 12.0 3.5% 22.9 8.2% * 10.2 4.3% 12.8 4.2% NS NS *
CD11c+
MHC-II+ 49.1 2.3% 40.0 5.6% NS 43.2 14.1% 45.8 6.8% NS NS NS
CD86+ 22.7 3.8% 26.4 4.7% NS 22.4 2.4% 29.9 5.7% * NS NS
CD80+ 18.4 1.5% 16.9 3.4% NS 18.3 3.7% 21.2 3.7% NS NS NS
Splenocytes were analyzed in untreated mice or 2 d after CLP. Data are given as mean SD (n¼ 5–7). The columns labeled ‘S’ give the statistical
significances for untreated versus CLP-treated mice of the respective mouse line; the last column gives the statistical significances between the two
mouse lines within the untreated or the CLP-treated mice. Significance was calculated with Bonferroni post hoc test following a two-way ANOVA. NS:
no significant effect. *P< 0.05.
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this, we generated chimeric mice with a TNFR2-
deﬁcient hematopoietic system in a WT host. Splenic
DC of these chimeric mice did not show impaired IL-12
production capacity: splenic DC of WT-in-WT control
chimeric mice stimulated ex vivo with CpG showed
4.6 0.5% IL-12p40-producing cells, and splenic DC
from TNFR2-deﬁcient-in-WT chimeric mice demon-
strated 5.1 1.0% IL-12p40-producing DC after CpG
stimulation. Similarly, BMDC created from these
chimeric mice did not show a diﬀerence in IL-12-
production (261.3+2.3 pg/ml in WT-in-WT and
225.6+147 pg/ml IL-12p70 in TNFR2-deﬁcient-
in-WT). These data indicate that the reduced IL-12 pro-
duction of splenic DC in TNFR2-deﬁcient mice is an
acquired feature and not a genetically pre-determined
phenotype.
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Figure 1. WT or TNFR2-deficient mice were either left untreated or treated with CLP (naı¨ve WT: filled circles; CLP-treated WT:
open circles; naı¨ve TNFR2-deficient: filled squares; CLP-treated TNFR2-deficient mice: open squares). MACS-purified DC were
prepared from splenocytes 2 d after CLP (a, b, d) or blood cells were prepared from naı¨ve mice (c) and cultured in the presence of
CpG. (a) IL-12p70 was determined in supernatant after 18 h of culture. (b, c) IL-12p40+ DC were detected after 4 h of culture. (a–c)
Each symbol represents a mouse; line indicates mean. *Statistically significant difference. (d) mRNA levels were determined after 6 h of
culture. Bars indicate the mean mRNA levels of technical replicates. (e) MACS-purified splenic DC were cultured in presence of CFSE-
labeled OT-II CD4+ T cells and varying concentrations of OVA. 3d, proliferation of CD4+ T cells was analyzed. Symbols indicate the
mean of technical replicates.
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Ag presentation is not diminished in
TNFR2-deficient DC
Besides IL-12 production, activation of T cells is an
important function of DC. We have previously shown
that sepsis induced by CLP impaired the capacity for
Ag (OVA) presentation of splenic DC from WT mice
resulting in reduced T cell proliferation.18 Surprisingly,
Ag-presenting splenic DC from naı¨ve TNFR2-deﬁcient
mice showed an enhanced capacity for induction of T
cell proliferation compared to DC from WT mice
(Figure 1e). However, CLP markedly reduced the T
cell activation capacity of DC from TNFR2-deﬁcient
mice, demonstrating a pronounced sepsis-induced
suppressive eﬀect by splenic TNFR2-deﬁcient DC.
The sepsis-induced shift in proliferation-stimulating
activity of DC isolated from TNFR2-deﬁcient mice
can not be explained by a clear shift of expression of
activation markers on the DC (as shown in Table 2).
In contrast to TNFR2-deﬁcient DC, CLP hardly
aﬀected the supportive activity of WT DC for CD4 T
cell proliferation.
TNF production in healthy mice
As splenic DC of TNFR2-deﬁcient mice resembled DC
from post-septic WT mice in terms of IL-12 production
capacity, we searched for the common factor shared
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Figure 2. (a) mRNA from indicated tissues of naı¨ve WT mice was analyzed for TNF expression. (b) WT mice were pre-treated (pre-
treat.) with LPS, TNF or PBS as control and challenged with LPS 24 h later. Ninety min after challenge, spleens were harvested and IL-
12-producing cells were determined. (c–e) WT and TNFR2-deficient mice were pre-treated with P. acnes or PBS as a control and
challenged with LPS 7 d later (PBS-treated WT: filled circles; P. acnes-treated WT: open circles; PBS-treated TNFR2-deficient: filled
squares; P. acnes-treated TNFR2-deficient mice: open squares). Four h after challenge, spleen masses (a), total cell count in spleens (b)
and IFN-g levels in serum were determined. (a–e) Each symbol represents a mouse, line indicates mean. *Statistically significant
difference.
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between septic WT mice and naı¨ve TNFR2-deﬁcient
mice. As TNF is strongly increased during sepsis, we
wondered whether endogenous bioactive TNF levels
might be increased in naı¨ve TNFR2-deﬁcient mice
owing to the lack of scavenger-soluble TNFR2. This
idea was supported by our recently reported ﬁnding
of high levels (10–20 ng/ml) of soluble TNFR2 secreted
in the urine of naı¨ve WT mice.22 In order to determine
whether TNF is endogenously produced in WT mice,
TNF mRNA expression was measured in diﬀerent
organs of naı¨ve WT mice using TNF-deﬁcient mice as
control. The results clearly demonstrated that TNF is
expressed in naı¨ve WT mice in a number of tissues
(Figure 2a); TNF mRNA was below detection level
when isolated from the respective organs from TNF-
deﬁcient mice. However, owing to the technical prob-
lem of detection of low amounts of protein in urine, we
were not able to directly detect endogenous TNF in
serum or urine, neither in free form nor bound to
TNFR2.
TNF induces habituation in DC
In order to ﬁnd out whether exposure to TNF is able to
induce a state of tolerance in DC, WT mice were tested
in the model of LPS tolerance.23 Similar to the changes
in DC function observed after CLP, in vivo pre-
treatment with LPS before LPS challenge reduced the
proportion of IL-12-producing splenic DC (Figure
2b).24 To validate TNF as an eﬀector molecule in
habituation of DC function, we pre-treated WT mice
with TNF before LPS challenge. Similar to LPS pre-
treatment, TNF pre-treatment also reduced the levels of
IL-12-producing DC upon LPS challenge (Figure 2b).
DC from TNFR2-deficient mice are refractory to
P. acnes-induced hyper-sensitization
Because TNFR2-deﬁcient mice mounted mitigated
inﬂammatory responses compared to WT mice after
CLP, we assumed that hyper-sensitization to LPS
might also be moderated in these mice. Therefore, we
subjected TNFR2-deﬁcient mice to the well-established
model for induction of LPS hyper-sensitivity by
P. acnes injection.25,26 As expected, compared with
WT mice sensitized with P. acnes, TNFR2-deﬁcient
mice displayed a signiﬁcantly smaller splenomegaly
upon LPS challenge (Figure 2c, d). IFN-g serum
levels were also signiﬁcantly lower in TNFR2-deﬁcient
mice than in WT mice (Figure 2e). Thus, TNFR2-
deﬁcient mice were not hyper-sensitized by P. acnes as
strongly as WT mice.
Discussion
So far, no clear picture of TNFR2 functions has
emerged from the use of mice with a genetically ablated
TNFR2 gene. For example, TNFR2-deﬁcient mice
have been described to be protected from TNF-induced
death and tissue necrosis,14 from neurovascular lesions
in experimental cerebral malaria,27,28 and from experi-
mentally-induced glomerulonephritis.29 Cooperative
eﬀects of both TNF receptors seemed to aggravate
TNF-induced arthritis11 and liver toxicity in experi-
mental hepatitis.30 In support of these ﬁndings, mice
over-expressing human TNFR2 displayed increased
pathology.31 Thus, activation of TNFR2 clearly
seemed to contribute to inﬂammation-induced tissue
damage. However, in other models, such as in retinal
ischemia32 and pulmonary edema,33 the lack of TNFR2
exacerbated pathological eﬀects, and selective activa-
tion of TNFR2 had a protective eﬀect in oxidative
stress-induced neurodegeneration.34 Ambiguous func-
tions of TNFR2 were seen in the formation and main-
tenance of granuloma in mycobacterial infections35 and
in experimental autoimmune encephalomyelitis where
TNFR1 appeared to be required for the initiation of
pathology, while TNFR2 was found to exacerbate the
disease.5,36 Previous results from our group showed
that TNFR2-deﬁcient mice were neither protected
from septic death by pre-treatment with LPS37 nor
did they develop immunoparalysis in sepsis 2 d after
induction by CLP.12 These observations pointed to a
regulatory role of TNFR2 aﬀecting the immune status.
In this report we present data which show that a
mechanism of TNF-induced habituation to inﬂamma-
tory stimuli seems to operate in TNFR2-deﬁcient mice
at the level of myeloid cells. DC from naı¨ve TNFR2-
deﬁcient mice resembled DC of septic WT mice: septic
mice have reduced numbers of functionally impaired
DC,18,20,38,39 possibly owing to epigenetic regulation.21
However, the functionally impaired phenotype of pri-
mary DC from naı¨ve TNFR2-deﬁcient mice did not
reﬂect epigenetic modiﬁcation as TNFR2-deﬁcient
BMDC and splenic DC or BMDC from chimeric WT
mice with a TNFR2-deﬁcient hematopoietic system
were not functionally impaired. Thus, our ﬁndings con-
ﬁrm previous reports, i.e. DC isolated from septic mice
had an impaired capacity for IL-12 production,40 while
in vitro-generated DC from such septic mice did not
exhibit diminished IL-12 production but developed
into regulatory DC with impaired capacity for Th1
priming when injected into mice.41 Thus, the impaired
function of DC isolated from spleens of TNFR2-
deﬁcient mice does not seem to be a direct eﬀect of
epigenetic alterations in bone marrow DC precursors.
Lack of TNFR2 signaling could be a possible cause for
the impaired phenotype. In support of this idea was the
observation that TNFR2 seemed to provide a survival
signal for DC when they were generated in vitro from
bone marrow cells of TNFR2-deﬁcient mice.42
However, we show that the phenotype of DC from
naı¨ve TNFR2-deﬁcient mice resembled DC from
septic WT mice. Lack of TNFR2 signaling cannot be
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the reason for the impaired IL-12 response in sepsis as
TNFR2 is strongly induced in inﬂammatory settings.
Furthermore, in the well-established model of LPS-
tolerance, naı¨ve WT mice pre-treated with LPS
responded in a similar fashion as WT mice 2 d after
CLP with reduced IL-12 production. As both sepsis
and LPS pre-treatment cause release of TNF, we inves-
tigated the impact of TNF pre-treatment on WT mice.
Indeed, WT mice pre-treated with TNF demonstrated a
phenotype similar to LPS pre-treated or septic mice
with a prominent reduction in IL-12-producing DC.
As we found that TNF induced a refractory state in
DC, we tested whether endogenous TNF is present in
healthy mice. As direct identiﬁcation of TNF from
urine and serum was below the detection limit, TNF
mRNA expression was measured and found in multiple
organs. Others have previously shown that endogenous
TNF in naı¨ve mice is necessary for the homeostatic
development of T cells without any on-going immune
reaction, which clearly demonstrates that biologically
active TNF is continuously present in healthy ani-
mals.43 Together with our previous ﬁnding of endogen-
ous soluble TNFR2 secreted with urine from healthy
WT mice,22 it is plausible that endogenous TNF is con-
stantly sequestered bound to soluble TNFR2. Hence,
mice deﬁcient in TNFR2 may continuously or repeat-
edly become exposed to biologically active, non-
sequestered endogenous TNF, thereby training the
DC. The training seems to cause a shift in the gener-
ation/recruitment of immature myeloid cells (MDSC)
as seen in sepsis (Table 1), confounding the maturation
of DC in response to inﬂammatory stimuli. This
habituation may also explain the refractoriness of
TNFR2-deﬁcient mice to hyper-sensitization by P.
acnes, in particular, as it has been shown that the
IFN-g response to P. acnes causing hyper-sensitization
critically depends on IL-12.44
It is important to note that DC from TNFR2-
deﬁcient mice were not completely non-functional.
DC from naı¨ve TNFR2-deﬁcient mice induced stronger
T cell proliferation than DC obtained from naı¨ve WT
mice even though no enhanced expression of activation
markers was measured on TNFR2-deﬁcient DC (Table
2). This observation and the fact that CLP induced a
clear inversion of the proliferation-stimulating activity
of DC isolated from the two mouse lines demonstrate
that additional mechanisms such as regulatory cells
might be at work for the manifestation of in vivo sup-
pression in sepsis. Interestingly, the appearance of regu-
latory T cells in sepsis was impaired in TNFR2-
deﬁcient mice.13 The diﬀerential reaction of WT and
TNFR2-deﬁcient mice to CLP-induced sepsis strongly
reducing the numbers of inﬂammatory myeloid cells in
septic WT mice, whereas no change was induced in
TNFR2-derived inﬂammatory myeloid cell numbers
points to a role of these potentially suppressive imma-
ture myeloid cells in the habituated phenotype observed
with TNFR2-deﬁcient mice. However, whether TNFR2
signaling plays a role in cells participating in this inter-
action remains to be analyzed.
In conclusion, TNF exposure habituates DC leading
to reduced IL-12 responses. This eﬀect is prevented by
TNFR2 in naı¨ve mice, but emerges after exposure to
high levels of TNF during inﬂammation or when
endogenous TNFR2 is missing. As we have recently
shown in the model of immune complex-induced glom-
erulonephritis,22 this training of DC leads to adapted
responses following inﬂammatory reactions. Obviously,
previous exposure to endogenous TNF is capable of
conferring such a suppression-inducing phenotype on
DC in TNFR2-deﬁcient mice.12 This calls for a careful
interpretation of data obtained with TNFR2-deﬁcient
mice as training by endogenous TNF and not (only)
lack of TNFR2 signal transduction will impact on the
results in such experimental models.
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